Medycyna Wieku Rozwojowego

774
Teresa Jackowska i wsp.
morbidity and mortality in patients with congestive heart failure. J. Am. Coll. Cardiol., 2000,
36(5), 1587-1593.
19. McNairy M., Gardetto N., Clopton P., Garcia A., Krishnaswamy P., Kazanegra R., Ziegler
M., Maisel A.S.: Stability of B-type natriuretic peptide levels during exercise in patients with
congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide.
Am. Heart. J., 2002, 143(3), 406-411.
20. Dasgupta A., Chow L., Tso G., Nazareno L.: Stability of NT-proBNP in serum specimens
collected in Becton Dickinson Vacutainer (SST) tubes. Clin. Chem., 2003, 49(6), 958-960.
21. Nowatzke W.L., Cole T.G.: Stability of N-terminal pro-Brain Natriuretic Peptide after storage
frozen for one year and after multiple freeze-thaw cycles. Clin. Chem., 2003, 49(9), 1560-
-1562.
22. Apple F.S., Panteghini M., Ravkilde J., Mair J., Wu A.H., Tate J., Pagani F., Christenson
R.H., Jaffe A.S.: Committee on Standardization of Markers of Cardiac Damage of the IFCC;
Quality specifications for B-type natriuretic peptide assays. Clin. Chem., 2005, 51(3), 486-493.
23. Goetze J.P.: Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine
heart revisited. Clin. Chem., 2004, 50(9), 1503-1510.
24. Hammerer-Lercher A., Ludwig W., Falkensammer G., Muller S., Neubauer E., Puschendorf
B., Pachinger O., Mair J.: Natriuretic peptides as markers of mild forms of left ventricular dysfunction:
effects of assays on diagnostic performance of markers. Clin. Chem., 2004, 50(7),
1174-1183.
Teresa Jackowska
Katedra i Klinika Pediatrii,
Hematologii i Onkologii
Akademii Medycznej w Warszawie
ul. Marsza∏kowska 24
00-576 Warszawa
e-mail: tjackow@amwaw.edu.pl